Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1230429

CC(C)[O-].CC(C)[O-].[Al+3].[Cl-]

nearest known ligand 0.30

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1228558 1.00
SCHEMBL242908 0.94 ALDH1A1 (0.33) ALDH1A1TSHRHSD17B10
SCHEMBL27502661 0.94 ALDH1A1 (0.33) ALDH1A1TSHRHSD17B10
SCHEMBL27287 0.94 ALDH1A1 (0.33) ALDH1A1TSHRHSD17B10
Hydrochloric Acid SCHEMBL5918575 0.88
Hydrochloric Acid SCHEMBL1230150 0.88 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
SCHEMBL1923724 0.88 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
Hydrochloric Acid SCHEMBL438557 0.88 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
SCHEMBL531269 0.88 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
Hydrochloric Acid SCHEMBL10333490 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1746134-B1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS KANEKA CORP (JP) 2019-09-04 EP disclosed
EP-1746135-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-05-29 EP disclosed
US-7973108-B2 Curable composition KANEKA CORPORATION (JP) 2011-07-05 US disclosed
US-7910681-B2 Curable composition having improved adhesion KANEKA CORPORATION (JP) 2011-03-22 US disclosed
US-7893170-B2 Curable composition having improved curability and adhesion KANEKA CORPORATION (JP) 2011-02-22 US disclosed
US-20080319152-A1 Curable Composition KANEKA CORPORATION (JP) 2008-12-25 US disclosed
US-20080194773-A1 Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-08-14 US disclosed
US-20080076878-A1 Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-03-27 US disclosed
CN-1297514-C Method for producing ceramic foams CELLARIS LTD (IL) 2007-01-31 CN disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746133-A1 CURABLE COMPOSITION IMPROVED IN ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746135-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed
CN-1304390-A Method for producing ceramic foams CELLARIS LTD (IL) 2001-07-18 CN disclosed
CN-1238327-A Stereoselective reduction of carbonyl compounds HOFFMANN LA ROCHE (CH) 1999-12-15 CN disclosed